Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now OTC Markets OTCPK - Delayed Quote • USD Adia Nutrition, Inc. (ADIA) Follow Compare 0.0900 +0.0167 +(22.78%) At close: February 21 at 3:38:12 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations ADIA Nutrition Proudly Launches Adia Labs LLC and Begins Sales of Branded Stem Cell Products Winter Park, Florida--(Newsfile Corp. - February 20, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare and supplementation, proudly announces the launch of Adia Labs LLC, a new division dedicated to advancing regenerative medicine. This initiative underscores ADIA Nutrition's commitment to providing high-quality products for the research and medical community.To view an enhanced version of this graphic, please visit:https:/https://finance.yahoo.com/images.newsfilecorp.com/files/10520/240585_img_5 Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products Winter Park, Florida--(Newsfile Corp. - February 18, 2025) - Adia (OTC Pink: ADIA) Med is proud to announce a strategic partnership with an FDA-approved laboratory in the field of regenerative medicine. This collaboration marks a new era in the availability of top-tier, third-party verified, and minimally manipulated umbilical cord stem cell and exosome products.Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome ProductsTo view an enhanced versi Adia Med Advances Towards AHCA Registration to Expand Insurance Coverage for Stem Cell Therapies Winter Park, Florida--(Newsfile Corp. - February 13, 2025) - Adia Med, the medical division of Adia Nutrition Inc. (OTC Pink: ADIA), proudly announces its ongoing registration with the State of Florida's Agency for Health Care Administration (AHCA). This crucial initiative is designed to secure approval for accepting private insurance for Adia Med's pioneering stem cell therapies including Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatment and injectable stem cells, thereby inc ADIA Nutrition Inc. Identifies Historical Share Issuance Issues; Commits to Retiring over 25 Million Shares Winter Park, Florida--(Newsfile Corp. - February 11, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in health and wellness solutions, has uncovered issues with share issuance from over a decade ago. Following an internal review, it was discovered that around 25 million shares were either issued or committed without proper documentation. This includes 15 million shares currently outstanding and 10 million shares promised in an agreement to pay, prior to the current ... Adia Nutrition Advances Towards OTCQB Uplisting with Third-Party Audit and Provides Roadmap to Listing on Nasdaq Small Cap WINTER PARK, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), an innovator nutritional products and medical treatments, has announced that through collaboration with Adia’s accountant, Adia has appointed a PCAOB (Public Company Accounting Oversight Board) accounting firm to conduct a comprehensive third-party audit. This strategic move is part of Adia's plan to uplist its shares from the OTC Pink Sheets to the OTCQB Venture Market, aiming to enhance visibility, attra Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location WINTER PARK, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), through its medical division Adia Med, is strategically positioning itself to capture a significant share of the growing $15.1 billion global stem cell market. Adia Med’s clinic in Winter Park, Florida, now offers stem cell treatments utilizing 361 human cell, tissue, and cellular and tissue-based products (HCT/Ps), aiming to provide an experience comparable to some of the world’s most recognized locations Adia Nutrition Unveils Exclusive Artwork by Renowned Performance Artist Rock Demarco at First Clinic WINTER PARK, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition is excited to announce the installation of an exclusive artwork by the renowned performance artist and speed painter, Rock Demarco, at its clinic. This unique piece, which blends painting with 3D sculptural elements, now adorns the clinic's main reception area, symbolizing transformation and rebirth through the poignant imagery of butterflies and stem cells. After his initial visit to the clinic, Rock Demarco felt deeply inspire Adia Nutrition Opens Doors in Winter Park, FL, Now Accepting Patients for AHSCT and Regenerative Therapies WINTER PARK, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition is thrilled to announce the opening of its inaugural clinic in Winter Park, Florida. The state-of-the-art facility is now accepting patients for groundbreaking treatments, including Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis (MS) and various regenerative therapies utilizing stem cells and platelet-rich plasma (PRP). Located at the heart of Winter Park, the clinic is designed to provide a nu Stem Cells, Superstars, And Supershow: WWE Superstar Elias Set to Face Off at WrestleCade SuperShow 2024 This Weekend WINTER PARK, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition (OTC Pink: ADIA) is proud to announce that this weekend, Jeff Sciullo, known in the wrestling world as Elias from WWE and business partner to ADIA Nutrition in their Cement Factory venture, will compete against Psycho Boy Fodder at the 2024 WrestleCade SuperShow. Psycho Boy Fodder and his team manage the marketing as well as the website design for Cement Factory. This match, organized by a third party, showcases the diverse inte Adia Nutrition Secures Lease for First Clinic in Winter Park, Florida WINTER PARK, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. proudly announces the signed lease for their state-of-the-art clinic, set to open in the distinguished Winter Park Medical Center. This clinic not only marks Adia Nutrition's inaugural venture into physical medical facilities but also introduces a rare stem cell extraction department, a feature shared by only a handful of clinics nationwide. The newly leased clinic comes fully built-out and recently remodeled, providing an Adia Nutrition Inc. Takes Major Steps Forward: Signs LOI for First Clinic and Engages Legal Expertise for Licensing WINTER PARK, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition (OTC Pink: ADIA) is proud to announce a groundbreaking initiative in the fight against Multiple Sclerosis (MS) with the signing of a Letter of Intent (LOI) to lease a new clinic in Winter Park, Florida. The clinic, which will offer Autologous Hematopoietic Stem Cell Transplantation (AHSCT) specifically for MS treatment, represents a significant leap forward in personalized health care, well ahead of the company's initial expansi Appointment of Dr. Kalpesh Barot, MD Completes Phase One of ADIA Nutrition’s Medical Division WINTER PARK, Fla., Sept. 24, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition (OTC Pink: ADIA) is excited to announce the completion of its Board of Medical Directors with the appointment of Dr. Kalpesh Barot, MD, a distinguished oncologist from the Southwest Cancer Center. This decision comes unanimously from the Board, led by Dr. Monica Sher, MD, and Dr. Richard Edwards, DO, in recognition of Dr. Barot’s exceptional qualifications and experience. Dr. Barot’s impressive resume and extensive expertise in ADIA Nutrition Stakes Claim in $6.7B Industry with Strategic Trademark Expansion WINTER PARK, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition Inc. (OTC Pink: ADIA) has announced the hiring of a prominent Winter Springs law firm to fortify its intellectual property holdings, specifically for its flagship product line under the "Biolete" brand. This strategic move aims to safeguard ADIA's intellectual property in the rapidly expanding markets for high-protein and mushroom-infused coffee products. The current Trademark "Biolete,” will be expanded to newly registered tra ADIA Nutrition Appoints Dr. Richard Edwards, DO as Second Medical Director WINTER PARK, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition (OTC Pink: ADIA) is excited to announce the appointment of Dr. Richard Edwards, DO, as its second Medical Director. Dr. Edwards joins Dr. Monica Sher, MD, to form a diverse and highly experienced board of medical directors. This strategic expansion underscores Adia Nutrition’s commitment to providing exceptional care and advancing innovative treatments in the field of autologous Hematopoietic Stem Cell Transplantation (aHSCT). ADIA Nutrition Plans For aHSCT Clinic in Winter Park, Florida Winter Park, Florida--(Newsfile Corp. - September 3, 2024) - ADIA Nutrition (OTC Pink: ADIA), a trailblazer in health and wellness, has opted to lease rather than purchase its inaugural medical clinic dedicated to treating Multiple Sclerosis (MS) patients with Autologous Hematopoietic Stem Cell Transplantation (aHSCT).Following a recent poll on the X platform, ADIA Nutrition's voters overwhelmingly supported the decision to lease the first clinic location. The company's board of directors also a ADIA Nutrition Inc. Provides Shareholder Update on Acquisition of Biolete Inc. and Financial Position Winter Park, Florida--(Newsfile Corp. - August 27, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA) is pleased to provide a shareholder update regarding its recent acquisition of Biolete Inc. and its financial position.As part of the acquisition, ADIA Nutrition has acquired not only the Biolete corporation and its trademark but also its current customer base, which has been generating revenue for Biolete. Additionally, ADIA Nutrition has taken possession of the Biolete Coffee inventory, from ... ADIA Nutrition Inc Appoints First Doctor of Its Medical Division Winter Park, Florida--(Newsfile Corp. - August 20, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA) has appointed Dr. Monica Sher as one of the Directors of its Medical Division, where she will be instrumental in helping to establish the policies and procedures for the company's Autologous Hematopoietic Stem Cell Transplantation (aHSCT) program for Multiple Sclerosis (MS) patients.Dr. Monica SherTo view an enhanced version of this graphic, please visit:https:/https://finance.yahoo.com/images.newsfilecorp.com/files/10520/220 ADIA Nutrition Hires Marketing Company to Boost Social Media Presence and Expand Advertising Efforts for Supplement Division Winter Park, Florida--(Newsfile Corp. - August 15, 2024) - Adia Nutrition Inc. (OTC Pink: ADIA), a growing health and wellness company, has announced a strategic partnership with Cornerstone Marketing Inc, a premier marketing and advertising firm, to enhance the brand's social media presence and expand its advertising efforts across its entire product line, including the popular "Biolete Coffee," now available on Amazon (Amazon.com: The Mushroom Coffee with 10 Grams of Protein by Biolete Premium ADIA Nutrition Inc. Announces Strategic Expansion of Biolete Coffee to Amazon Winter Park, Florida--(Newsfile Corp. - August 13, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovator in the nutritional supplement industry, is excited to announce the approval of their very own Biolete Coffee on the global e-commerce giant, Amazon(Amazon.com: The Mushroom Coffee with 10 Grams of Protein by Biolete Premium Coffee Extract with Collagen, Chaga, Lions Mane & L-Theanine 20 Servings : Grocery & Gourmet Food). This strategic move marks a significant milestone ... ADIA Nutrition Inc. Announces Registration with RangeMe and Submission for Walmart's Open Call Winter Park, Florida--(Newsfile Corp. - August 6, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce its recent registration with RangeMe, a leading product discovery platform, and the submission of an application for Walmart's Open Call event in September.The registration with RangeMe allows ADIA Nutrition to showcase its unique product, Biolete, to over 15,000 buyers from various retailers, including Walmart, CVS, and 7-11 to Performance Overview Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return ADIA S&P 500 YTD +1,185.71% +2.24% 1-Year +350.00% +20.70% 3-Year +800.00% +38.27%